Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Metabolism of a potent neuroprotective hydrazide
It increases H3K4 methylation selectively at genomic regions bound by LSD1
N106 was used at 10 µM final concentration in vitro and in cellular assays
Formula: C17H15BrF2N4O3
Canertinib HCl - CAS# 289499-45-2 60273 Metabolism of a potent neuroprotectiveCanertinib, also known as CI1033 and PD183805, CAS No. 289499 45 2, is a potent ErbB inhibitor for the treatment of cancer. It is an irreversible tyrosine kinase inhibitor with activity against EGFR (IC50 0. 8 nM), HER 2 (IC50 19 nM) and ErbB 4 (IC50 7 nM). By 2015, Pfizer had discontinued development of the drug. Canertinib has been reported as a substrate for OATP1B3. Interaction of canertinib with OATP1B3 may alter its hepatic disposition and can
US$ 180.00
US$ 180.00
US$ 250.00
US$ 60.00
US$ 145.00
US$ 75.00
US$ 135.00
US$ 130.00
US$ 170.00
US$ 165.00
US$ 156.00
US$ 125.00
US$ 200.00